Full Text View
Tabular View
No Study Results Posted
Related Studies
Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant
This study is ongoing, but not recruiting participants.
Study NCT00970073   Information provided by The Cleveland Clinic

First Received on August 31, 2009.   Last Updated on March 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Transplantation
Interventions listed in this trial
Thymoglobulin
Mycophenolate mofetil
tacrolimus
Additional drug interventions recognized in this trial
Mycophenolic Acid
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
The Cleveland Clinic
Genzyme


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services